36th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180250323 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ADAMTS-5 AND ADAM17 | 2018-09-06 |
20180250324 | PREBIOTIC FORMULATIONS AND METHODS OF USE | 2018-09-06 |
20180250325 | MIR-19 MODULATORS AND USES THEREOF | 2018-09-06 |
20180250326 | COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING LOW MOLECULAR WEIGHT HYALURONIC ACID AND ASTAXANTHIN | 2018-09-06 |
20180250327 | ANTIVIRAL PHARMACEUTICAL COMPOSITION FOR TOPICAL USE | 2018-09-06 |
20180250328 | Metallocene-boronic acid-containing compounds and copolymers as antimicrobial agents. | 2018-09-06 |
20180250329 | USE OF INHALED GASEOUS NITRIC OXIDE AS A MUCOLYTIC AGENT OR EXPECTORANT | 2018-09-06 |
20180250330 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | 2018-09-06 |
20180250331 | Method for Poly Signal Activation of Apoptosis of Malignant Solid Tumour Cells | 2018-09-06 |
20180250332 | Polymer Conjugate Of Hexa-Coordinated Platinum Complex | 2018-09-06 |
20180250333 | Nanoceria For The Treatment of Oxidative Stress | 2018-09-06 |
20180250334 | TRACE ELEMENTS | 2018-09-06 |
20180250335 | MODIFIED CELLS EVOKING REDUCED IMMUNOGENIC RESPONSES | 2018-09-06 |
20180250336 | COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS | 2018-09-06 |
20180250337 | GENETICALLY ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME | 2018-09-06 |
20180250338 | TUMOR INFILTRATING LYMPHOCYTES FOR TREATMENT OF CANCER | 2018-09-06 |
20180250339 | METHODS AND COMPOSITIONS FOR GENE EDITING IN HEMATOPOIETIC STEM CELLS | 2018-09-06 |
20180250340 | METHODS FOR REJUVINATING RED BLOOD CELLS | 2018-09-06 |
20180250341 | METHOD OF REPAIRING DAMAGED BLOOD-SPINAL CORD BARRIER (BSCB) | 2018-09-06 |
20180250342 | MODULATION OF SPLENOCYTES IN CELL THERAPY | 2018-09-06 |
20180250343 | THERAPEUTIC COMPOSITIONS | 2018-09-06 |
20180250344 | LITHIUM STIMULATION OF CORD BLOOD STEM CELL PROLIFERATION AND GROWTH FACTOR PRODUCTION | 2018-09-06 |
20180250345 | VEGFR-2 TARGETING DNA VACCINE FOR COMBINATION THERAPY | 2018-09-06 |
20180250346 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2018-09-06 |
20180250347 | USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS | 2018-09-06 |
20180250348 | METHODS AND COMPOSITIONS USING BIFIDOBACTERIUM LONGUM TO TREAT OR PREVENT DEPRESSIVE SYMPTOMS | 2018-09-06 |
20180250349 | METHODS AND COMPOSITIONS USING BIFIDOBACTERIUM LONGUM TO MODULATE EMOTIONAL REACTIVITY AND TREAT OR PREVENT SUB-CLINICAL MOOD DISTURBANCES | 2018-09-06 |
20180250350 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES | 2018-09-06 |
20180250351 | Cyanobacterial microalgae phycocyanin and phycocyanobilin to beneficially inhibit the activity of the UDP-GDH enzyme while significantly increasing the absorption and circulation of curcumin | 2018-09-06 |
20180250352 | TREATMENT OF CANCER BY INFUSION OF ONCOLYTIC HERPES SIMPLEX VIRUS TO THE BLOOD | 2018-09-06 |
20180250353 | CEACAM BASED ANTIBACTERIAL AGENTS | 2018-09-06 |
20180250354 | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS | 2018-09-06 |
20180250356 | TARGETING G3BP PROTEINS TO ACCELERATE NERVE REGENERATION | 2018-09-06 |
20180250357 | METHODS COMPRISING DESMOPRESSIN | 2018-09-06 |
20180250358 | GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS | 2018-09-06 |
20180250359 | COMBINATION THERAPY USING GLIADIN AND GAMMA AMINOBUTYRIC ACID | 2018-09-06 |
20180250360 | METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER | 2018-09-06 |
20180250361 | Methods, Compounds and Compositions for Modulating Blood Brain Barrier Integrity and Re-myelination | 2018-09-06 |
20180250362 | Methods of Treating Fungal Infections | 2018-09-06 |
20180250363 | Pegylated Interleukin-10 | 2018-09-06 |
20180250364 | Methods of Using Interleukin-10 for Treating Diseases and Disorders | 2018-09-06 |
20180250365 | ACTH FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | 2018-09-06 |
20180250366 | COMPOSITIONS AND METHODS FOR PROTECTING THE KIDNEY FROM ISCHEMIA REPERFUSION INJURY | 2018-09-06 |
20180250367 | POLYMER-FACTOR VIII MOIETY CONJUGATES | 2018-09-06 |
20180250368 | LIQUID COMPOSITION OF HUMAN ALBUMIN FOR THERAPEUTIC USE | 2018-09-06 |
20180250369 | LACTOFERRIN COMPOSITIONS AND METHODS FOR MODULATION OF T CELL SUBTYPES AND TREATMENT OF AUTOIMMUNE DISEASES | 2018-09-06 |
20180250370 | TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES | 2018-09-06 |
20180250371 | CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE | 2018-09-06 |
20180250372 | COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION | 2018-09-06 |
20180250373 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS | 2018-09-06 |
20180250374 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS | 2018-09-06 |
20180250375 | NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE | 2018-09-06 |
20180250376 | MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN | 2018-09-06 |
20180250377 | BACILLUS BASED DELIVERY SYSTEM AND METHODS OF USE | 2018-09-06 |
20180250378 | COMBINATION OF THERAPEUTIC VACCINE AND PD-1-RELATED BLOCKADE FOR TREATING HUMAN PAPILLOMAVIRUS-ASSOCIATED DISEASES | 2018-09-06 |
20180250379 | GENERATION OF HPV-SPECIFIC T-CELLS | 2018-09-06 |
20180250380 | TREATMENT OF PIGS WITH PCV2 ANTIGEN | 2018-09-06 |
20180250381 | SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES | 2018-09-06 |
20180250382 | Inactivated Canine Influenza Vaccines and Methods of Making and Uses Thereof | 2018-09-06 |
20180250383 | Methods of Treating and Preventing Influenza Infections | 2018-09-06 |
20180250384 | IMMUNOGENIC ANTIGEN IDENTIFICATION FROM A PATHOGEN AND CORRELATION TO CLINICAL EFFICACY | 2018-09-06 |
20180250385 | METHODS FOR INDUCING PROTECTIVE IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION | 2018-09-06 |
20180250386 | COMBINATION THERAPIES FOR HUMAN PAPILLOMAVIRUS-ASSOCIATED DISEASES COMPRISING ADMINISTRATION OF THERAPEUTIC VACCINE AND RECOMBINANT VIRUS VECTOR | 2018-09-06 |
20180250387 | COMPOSITIONS AGAINST CAT ALLERGY | 2018-09-06 |
20180250388 | TREATMENT OF INSECT BITE HYPERSENSITIVITY | 2018-09-06 |
20180250389 | VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES | 2018-09-06 |
20180250390 | PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | 2018-09-06 |
20180250391 | COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE | 2018-09-06 |
20180250392 | HUMAN ANTI-VEGFR-2/KDR ANTIBODIES | 2018-09-06 |
20180250393 | MANIPULATION OF T CELL AND MAST CELL ACTIVATION BY PIK3IP1 | 2018-09-06 |
20180250394 | MIT BIOMARKERS AND METHODS USING THE SAME | 2018-09-06 |
20180250395 | CD47 ANTIBODIES, METHODS, AND USES | 2018-09-06 |
20180250396 | BISPECIFIC ANTIBODIES FOR USE IN CANCER IMMUNOTHERAPY | 2018-09-06 |
20180250397 | ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER | 2018-09-06 |
20180250398 | CO-THERAPY COMPRISING A SMALL MOLECULE CSF-1R INHIBITOR AND AN AGONISTIC ANTIBODY THAT SPECIFICALLY BINDS CD40 FOR THE TREATMENT OF CANCER | 2018-09-06 |
20180250400 | Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK4/6 Inhibitor | 2018-09-06 |
20180250401 | STABILIZATION OF IMMUNOGLOBULINS THROUGH AQUEOUS FORMULATION WITH HISTIDINE AT WEAK ACIDIC TO NEUTRAL PH | 2018-09-06 |
20180250402 | LIGHT-RESPONSIVE POLYPEPTIDES AND METHODS OF USE THEREOF | 2018-09-06 |
20180250403 | CONJUGATES | 2018-09-06 |
20180250404 | HIGH-Z NANOPARTICLES AND THE USE THEREOF IN RADIATION THERAPY | 2018-09-06 |
20180250405 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | 2018-09-06 |
20180250406 | RS7 Antibodies | 2018-09-06 |
20180250407 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2018-09-06 |
20180250408 | OPHTHALMIC COMPOSITION | 2018-09-06 |
20180250409 | PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR | 2018-09-06 |
20180250410 | MODIFIED POLY (BETA-AMINO ESTER)S FOR DRUG DELIVERY | 2018-09-06 |
20180250411 | DERMATOLOGICAL COMPOSITIONS AND METHODS USING SAME | 2018-09-06 |
20180250412 | FUNCTIONAL HYDRATED HYALURONIC ACID AND METHOD FOR PRODUCING COATED LACTIC ACID BACTERIA HAVING EXCELLENT INTESTINAL MUCOADHESIVE ABILITY AND SELECTIVE ANTAGONISTIC ACTION USING SAME | 2018-09-06 |
20180250413 | TARGETED DELIVERY OF DRUGS, THERAPEUTIC NUCLEIC ACIDS AND FUNCTIONAL NUCLEIC ACIDS TO MAMMALIAN CELLS VIA INTACT KILLED BACTERIAL CELLS | 2018-09-06 |
20180250414 | PEPTIDE-BASED MULTIPLE-DRUG DELIVERY VEHICLE | 2018-09-06 |
20180250415 | DUAL VARIABLE DOMAIN IMMUNOCONJUGATES AND USES THEREOF | 2018-09-06 |
20180250416 | COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES | 2018-09-06 |
20180250417 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES | 2018-09-06 |
20180250418 | ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | 2018-09-06 |
20180250419 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | 2018-09-06 |
20180250420 | MULTIPLE HUMAN ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS OF FORMATION | 2018-09-06 |
20180250421 | COMPOSITION FOR TREATING PAIN | 2018-09-06 |
20180250422 | METHODS OF TREATING NEURODEGENERATIVE DISORDERS | 2018-09-06 |
20180250423 | METHODS AND MATERIALS FOR GALGT2 GENE THERAPY | 2018-09-06 |
20180250424 | COMPOSITIONS AND METHODS FOR PROMOTING HOMOLOGY DIRECTED REPAIR | 2018-09-06 |